<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20110228005931N11</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2021-12-22</date_registration>
      <primary_sponsor>Babol University of Medical Sciences</primary_sponsor>
      <public_title>Effect of internet-based emotion-focused therapy on the anxiety of women with a suspected fetal malformation</public_title>
      <acronym></acronym>
      <scientific_title>The effect of internet-based emotion-focused therapy on anxiety and pregnancy outcomes in anxious women with a suspected fetal malformation</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2021-11-22</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>408</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/59404</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Factorial, Purpose: Treatment, Other design features: A randomized controlled clinical trial with four-arm parallel, Randomization description: After checking inclusion and exclusion criteria, participants are allocated randomly into four groups by permuted block randomization method. The block size is 4 and by using the statistical software, Each block of each intervention group will be repeated once, As a result, we will have 35 different blocks, Then, using the statistical program in R software environment version 11, 35 blocks of 4 will be generated, which will produce a total of 140 sequences. Randomization is assigned by standalone statistical software using a computer random sequence to assign participants to one of four study groups using this randomly generated list.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Anxiety disorder.</hc_freetext>
      <i_freetext>Intervention 1: In this group, the participants will receive Internet emotion-focused therapy for six 90-minute sessions once a week. During the sessions, participants will interact with the content of the program via videos, text, audio, audio clips, therapist explanations, and relevant practices. During the therapy, patients will acquire necessary skills, including identifying and evaluating thoughts, recognizing emotions, and emotion management skills. Patients' assignments will be online both during the sessions and the week and will be sent to the therapist. The therapist will also reflect feedback on assignments to patients via SMS. Intervention 2: The participants of the group will be received IEFT( 6 sessions of online treatment with duration 90 minutes, once a week) with  6sessions of   mreminder dose (after treatment, one session every month for 6 months). Intervention 3: The participants of the group will be received IEFT( 6 sessions of online treatment with duration 90 minutes, once a week) with the participation of their husband during treatment. Intervention 4: The participants of the group will be received IEFT( 6 sessions of an online treatment with duration 90 minutes, once a week) with the participation of their husband during treatment, as well as reminder dose (after treatment, once session every month for 6 months ).</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is Undecided - It is not yet known if there will be a plan to make this available</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Dr. Mahbobeh Faramarzi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Babol University of Medical Sciences, GanjafrozAvenue, Babol, Mazandaran, Iran</address>
        <city>Babol</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>47745-47176</zip>
        <telephone>+98 11 1219 9592</telephone>
        <email>Mahbob330@yahoo.com</email>
        <affiliation>Babol University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Dr.Mahbobeh Faramarzi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Babol University of Medical Sciences, GanjafrozAvenue, Babol, Mazandaran, Iran</address>
        <city>Babol</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>47745-47176</zip>
        <telephone>+98 11 1219 9592</telephone>
        <email>Mahbob330@yahoo.com</email>
        <affiliation>Babol University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Gestational age of less than 20 weeks
Suspected of fetal malformation based on diagnosis by a gynecologist
Spielberger's anxiety score above 30
Educational level higher than primary school
Consent of the woman and her husband to enter treatment
َAccess to computers and the Internet</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Current substance abuse
Current use of sedative drugs like benzodiazepines, or recent psychotherapy for depression/anxiety (&lt;4 weeks)
Severe psychiatric disorders such as severe anxiety, sever depression, and suicidal thought</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>F41.9</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Anxiety disorder, unspecified</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>In this group, the participants will receive Internet emotion-focused therapy for six 90-minute sessions once a week. During the sessions, participants will interact with the content of the program via videos, text, audio, audio clips, therapist explanations, and relevant practices. During the therapy, patients will acquire necessary skills, including identifying and evaluating thoughts, recognizing emotions, and emotion management skills. Patients' assignments will be online both during the sessions and the week and will be sent to the therapist. The therapist will also reflect feedback on assignments to patients via SMS.</i_keyword>
      <i_keyword>The participants of the group will be received IEFT( 6 sessions of online treatment with duration 90 minutes, once a week) with  6sessions of   mreminder dose (after treatment, one session every month for 6 months)</i_keyword>
      <i_keyword>The participants of the group will be received IEFT( 6 sessions of online treatment with duration 90 minutes, once a week) with the participation of their husband during treatment.</i_keyword>
      <i_keyword>The participants of the group will be received IEFT( 6 sessions of an online treatment with duration 90 minutes, once a week) with the participation of their husband during treatment, as well as reminder dose (after treatment, once session every month for 6 months )</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>ََAnxiety. Timepoint: Before intervention, at the end of intervention (6 weeks post-trial ), follow-up of 3 and 6 months after the intervention. Method of measurement: Spielberger's anxiety questionnaire.</prim_outcome>
      <prim_outcome>ٍEmotion regulation. Timepoint: Before intervention, at the end of intervention (6 weeks post-trial ), follow-up of 3 and 6 months after the intervention. Method of measurement: Cognitive emotion regulation questionnaire.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Uncertainty intolerance. Timepoint: Before intervention, at the end of intervention (6 weeks post-trial ), follow-up of 3 and 6 months after the intervention. Method of measurement: Uncertainty Intolerance Questionnaire.</sec_outcome>
      <sec_outcome>Pregnancy stress. Timepoint: Before intervention, at the end of intervention (6 weeks post-trial ), follow-up of 3 and 6 months after the intervention. Method of measurement: Revised Pregnancy Distress Questionnaire (NuPDQ).</sec_outcome>
      <sec_outcome>Depression. Timepoint: Before intervention, at the end of intervention (6 weeks post-trial ), follow-up of 3 and 6 months after the intervention. Method of measurement: Edinburgh Postnatal depression questionnaire.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Babol University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2021-04-30</approval_date>
        <contact_name>Babol University of Medical Sciences</contact_name>
        <contact_address>Babol University of Medical Sciences, Ganjafroz Avenue, Babol, Mazandaran, Iran, Babol Babol Mazandaran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
